Quest Diagnostics Acquires ReproSource, Extending into Advanced Fertility Diagnostics

Quest Diagnostics, the world’s leading provider of diagnostic information services, announced it has acquired ReproSource, a national leader in specialty fertility diagnostic services. About 10 percent of women of child-bearing age in the United States have difficulty getting or staying pregnant, according to the Centers for Disease Control and Prevention. Woburn, Mass-based ReproSource provides a range of advanced diagnostic services, such as genetics-based ovarian health and recurrent pregnancy loss assessments, to help patients identify and surmount obstacles to fertility and pregnancy. “Our acquisition of ReproSource delivers on our accelerate growth strategy, particularly in advanced diagnostics, and our goal to deliver the broadest access to diagnostic innovation,” said Steve Rusckowski, Chairman, President and CEO, Quest Diagnostics.

“ReproSource is recognized for evidence-based expertise in reproductive diagnostics and will extend our breadth of services for providers and their patients.” Quest plans to offer ReproSource’s services nationally as part of its comprehensive women’s health and reproductive offerings for obstetricians, gynecologists, fertility specialists and other physicians. Quest is a leader in advanced diagnostics services that help guide women and their physicians through the reproductive journey. These services include the company’s proprietary QNatal noninvasive prenatal and QHerit carrier genetic screening services. – Medical Buyer Bureau